(Q37866795)

24 August 2017

1 reference

title

Second-line therapy for small-cell lung cancer (English)

1 reference

24 August 2017

0 references

1 reference

Alexander Schmittel

1

1 reference

24 August 2017

1 April 2011

1 reference

Expert Review of Anticancer Therapy

24 August 2017

1 reference

24 August 2017

11

1 reference

24 August 2017

4

1 reference

24 August 2017

631-637

1 reference

Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer

24 August 2017

1 reference

Open-label, multicenter, randomized, phase III study comparing oral topotecan/cisplatin versus etoposide/cisplatin as treatment for chemotherapy-naive patients with extensive-disease small-cell lung cancer

21 January 2018

1 reference

Topotecan in the treatment of elderly patients with relapsed small-cell lung cancer

21 January 2018

1 reference

Efficacy of a toxicity-adjusted topotecan therapy in recurrent small cell lung cancer

21 January 2018

1 reference

Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic Oncology Research Group Study 0301.

21 January 2018

1 reference

A phase II study of amrubicin, a synthetic 9-aminoanthracycline, in patients with previously treated lung cancer

21 January 2018

1 reference

Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer

21 January 2018

1 reference

Randomized phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0402.

21 January 2018

1 reference

Randomized phase II trial of single-agent amrubicin or topotecan as second-line treatment in patients with small-cell lung cancer sensitive to first-line platinum-based chemotherapy

21 January 2018

1 reference

A phase II study of paclitaxel in heavily pretreated patients with small-cell lung cancer

21 January 2018

1 reference

Activity of docetaxel (Taxotere) in small cell lung cancer. The Early Clinical Trials Group of the EORTC.

21 January 2018

1 reference

Phase II trial of second-line bendamustine chemotherapy in relapsed small cell lung cancer patients

21 January 2018

1 reference

Phase II trial of gemcitabine in refractory or relapsed small-cell lung cancer: Eastern Cooperative Oncology Group Trial 1597.

21 January 2018

1 reference

Combination of cisplatin, ifosfamide, and irinotecan with rhG-CSF support for the treatment of refractory or relapsed small-cell lung cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERA.11.7

1 reference

24 August 2017

1 reference

PubMed ID

21504329